Proveca Ltd
Emily Sheppard is an experienced professional in product development within the pharmaceutical industry, currently serving as Head of Product Development at Proveca Ltd since July 2021. Prior to this role, Emily held various positions at Teva Pharmaceuticals from January 2008 to July 2021, including Senior NPI Project Manager, where responsibilities encompassed project management of new combination product introductions and oversight of validation activities. Earlier experience includes positions as NPI Team Leader, NPI Technologist, and Analytical/Formulation Scientist at Teva. Emily’s career began at sanofi-aventis as an R&D Scientist from September 2005 to December 2007. Emily holds a Master of Science (MSc) in Pharmaceutical Industry Advanced Training and a Bachelor of Science (BSc) with Honours in Chemistry, both from The University of Manchester.
Proveca Ltd
Proveca Ltd is a pharmaceutical company specialising in identifying, researching and licensing off-patent medicines with unmet priority health care needs, with a focus on the paediatric market. By developing the necessary formulations and clinical data required to obtain a Paediatric Use Marketing Authorisation (PUMA) these drugs will benefit froma period of 10 years' market protection (8 years of data and market protection plus 2 further years of market protection). In addition, where appropriate, Orphan Drug status (Orphan Drug) will be sought which affords a period of 10 years' market exclusivity to run concurrently.Value will be realised through commercialisation of the licensed medicine or an outright sale of the licence to a larger pharmaceutical company.